Parkman Healthcare Partners LLC Neogenomics Inc Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$11.67 - $20.73 $93,943 - $166,876
-8,050 Reduced 3.27%
237,762 $3.85 Million
Q3 2023

Nov 14, 2023
BUY
$12.15 - $17.85 $121,074 - $177,875
9,965 Added 4.23%
245,812 $3.02 Million
Q2 2023

Aug 11, 2023
BUY
$14.1 - $19.83 $3.33 Million - $4.68 Million
235,847 New
235,847 $3.79 Million

Others Institutions Holding NEO

# of Institutions
294
Shares Held
124M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.69B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email